Dementia affects over 55 million people worldwide, with nearly 10 million new cases diagnosed annually. While age and genetics (particularly APOE4) remain the strongest risk factors, a landmark body of research—most comprehensively synthesized by the Lancet Commission on Dementia Prevention, Intervention, and Care—has established that approximately 45% of dementia cases globally could be potentially prevented or delayed by addressing 14 modifiable risk factors across the life course 1(. This figure increased from the 35% estimate in the 2017 report and 40% in 2020, following the addition of two newly identified risk factors—untreated vision loss and elevated LDL cholesterol—in the 2024 update 1(https://www.thelancet.com/commissions-do/dementia-prevention-intervention-and-care) 2(https://www.alzheimer-europe.org/news/2024-lancet-commission-underscores-potential-dementia-risk-reduction-identifying-14-modifiable?language_content_entity=en). The Commission's framework organizes these risk factors across three life phases: early life (younger than 45 years), midlife (45–65 years), and later life (older than 65 years) (Alzheimer et al., 2024) [1].
Lower educational attainment is one of the strongest modifiable risk factors for dementia. Education builds [cognitive reserve[/mechanisms/[cognitive-reserve[/mechanisms/[cognitive-reserve[/mechanisms/[cognitive-reserve--TEMP--/mechanisms)--FIX--—the brain's resilience to pathological damage—by strengthening synaptic networks, promoting neuroplasticity, and enhancing compensatory cognitive strategies 1(https://www.thelancet.com/commissions-do/dementia-prevention-intervention-and-care) (Livingston et al., 2024) [2].
- Individuals without secondary education have approximately 1.6 times the risk of developing dementia compared to those who complete secondary school.
- Education may influence lifelong occupational complexity, social engagement, and health literacy.
- Universal access to quality primary and secondary education is a population-level intervention with far-reaching cognitive benefits.
Hearing loss is the single largest modifiable risk factor for dementia globally. The mechanisms linking hearing impairment to cognitive decline include reduced auditory stimulation (leading to cortical atrophy in auditory regions), increased cognitive load from effortful listening, and social withdrawal 1(](https://www.thelancet.com/commissions-do/dementia-prevention-intervention-and-care) 3(https://www.ucl.ac.uk/news/2024/jul/nearly-half-dementia-cases-could-be-prevented-or-delayed-tackling-14-risk-factors) (Nearly et al., 2024) [3].
- Meta-analyses show that hearing aid use in individuals with hearing loss is associated with a 19% reduction in cognitive decline.
- The ACHIEVE randomized trial (2023) demonstrated that hearing intervention slowed cognitive decline by 48% in at-risk older adults over 3 years.
- Hearing loss affects over 60% of adults aged 60 and older globally.
Elevated midlife low-density lipoprotein (LDL) cholesterol emerged as a major newly identified risk factor in the 2024 Lancet Commission update, sharing the highest population attributable fraction alongside hearing loss 1(](https://www.thelancet.com/commissions-do/dementia-prevention-intervention-and-care) 2(https://www.alzheimer-europe.org/news/2024-lancet-commission-underscores-potential-dementia-risk-reduction-identifying-14-modifiable?language_content_entity=en) (Calvet et al., 2024) [4].
- High midlife LDL cholesterol is associated with increased [amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta--TEMP--/entities)--FIX-- deposition and [cerebral small vessel disease[/diseases/[cerebral-small-vessel-disease[/diseases/[cerebral-small-vessel-disease[/diseases/[cerebral-small-vessel-disease--TEMP--/diseases)--FIX--.
- Cholesterol plays a central role in [brain cholesterol metabolism], [APP[/genes/[app[/genes/[app[/genes/[app--TEMP--/genes)--FIX-- processing], and [amyloid aggregation[/mechanisms/[amyloid-aggregation[/mechanisms/[amyloid-aggregation[/mechanisms/[amyloid-aggregation--TEMP--/mechanisms)--FIX--.
- Statin use in midlife has been associated with reduced dementia risk in several observational studies, though randomized trial evidence for cognitive endpoints remains mixed.
- The [APOE4[/diseases/[apoe4[/diseases/[apoe4[/diseases/[apoe4--TEMP--/diseases)--FIX-- allele—the strongest genetic risk factor for late-onset AD—is involved in cholesterol transport, highlighting the intersection of genetic and metabolic risk.
Midlife hypertension is a well-established risk factor for both [Alzheimer's disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX-- and [Vascular Dementia[/diseases/[vascular-dementia[/diseases/[vascular-dementia[/diseases/[vascular-dementia--TEMP--/diseases)--FIX-- 1(https://www.thelancet.com/commissions-do/dementia-prevention-intervention-and-care) (Cognitive et al., 2024):
- Chronic hypertension damages the cerebral microvasculature, contributing to [Blood-Brain Barrier[/entities/[blood-brain-barrier[/entities/[blood-brain-barrier[/entities/[blood-brain-barrier--TEMP--/entities)--FIX-- breakdown, white matter lesions, and [cerebral small vessel disease[/diseases/[cerebral-small-vessel-disease[/diseases/[cerebral-small-vessel-disease[/diseases/[cerebral-small-vessel-disease--TEMP--/diseases)--FIX--.
- The SPRINT-MIND trial showed that intensive blood pressure lowering (target systolic < 120 mmHg) reduced the risk of mild cognitive impairment by 19%.
- Midlife treatment of hypertension is more protective than late-life treatment, as damage accumulates over decades.
[Traumatic brain injury[/diseases/[traumatic-brain-injury[/diseases/[traumatic-brain-injury[/diseases/[traumatic-brain-injury--TEMP--/diseases)--FIX-- (TBI), particularly moderate-to-severe and repetitive mild TBI, increases long-term dementia risk 1(https://www.thelancet.com/commissions-do/dementia-prevention-intervention-and-care) (Prevent et al., 2024):
- Single severe TBI increases dementia risk by 1.25–2.0 fold; repetitive TBI (as in contact sports) can lead to [chronic traumatic encephalopathy[/diseases/[cte[/diseases/[cte[/diseases/[cte--TEMP--/diseases)--FIX--.
- TBI triggers acute neuroinflammation, tau]] pathology], and accelerated [amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta--TEMP--/entities)--FIX-- deposition.
- Prevention strategies include helmet use, fall prevention programs, and sports rule modifications.
Regular physical exercise is one of the most consistent protective factors against dementia 1(https://www.thelancet.com/commissions-do/dementia-prevention-intervention-and-care):
- Exercise promotes [neurogenesis[/entities/[neurogenesis[/entities/[neurogenesis[/entities/[neurogenesis--TEMP--/entities)--FIX--, enhances BDNF expression, improves cerebrovascular health, and reduces neuroinflammation.
- Both aerobic exercise and resistance training show cognitive benefits in meta-analyses.
- WHO recommends 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity aerobic activity per week for adults.
- Physical activity also acts indirectly by reducing other risk factors: hypertension, diabetes, obesity, and depression.
Heavy alcohol use (>21 units/week) increases dementia risk through multiple mechanisms 1(https://www.thelancet.com/commissions-do/dementia-prevention-intervention-and-care):
- Direct neurotoxicity, thiamine deficiency (leading to [Wernicke-Korsakoff syndrome[/diseases/[wernicke-korsakoff-syndrome[/diseases/[wernicke-korsakoff-syndrome[/diseases/[wernicke-korsakoff-syndrome--TEMP--/diseases)--FIX--, and liver dysfunction.
- Alcohol-related brain damage, cerebral atrophy, and white matter degeneration.
- Moderate alcohol consumption (1–14 units/week) shows no consistent protective effect in newer Mendelian randomization studies.
Midlife obesity (BMI ≥ 30 kg/m²) is associated with increased dementia risk 1(](https://www.thelancet.com/commissions-do/dementia-prevention-intervention-and-care):
- Adiposity promotes systemic inflammation, [insulin resistance], and metabolic syndrome.
- Midlife (but not late-life) obesity predicts greater [amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta--TEMP--/entities)--FIX-- burden on PET imaging.
- Weight loss in late life may be a prodromal symptom of dementia rather than protective, complicating interpretation of late-life BMI studies.
Type 2 diabetes increases dementia risk by approximately 60%, mediated through both vascular and neurodegenerative pathways 1(https://www.thelancet.com/commissions-do/dementia-prevention-intervention-and-care):
- Chronic hyperglycemia causes advanced glycation end products that damage the neurovasculature and promote [amyloid aggregation[/mechanisms/[amyloid-aggregation[/mechanisms/[amyloid-aggregation[/mechanisms/[amyloid-aggregation--TEMP--/mechanisms)--FIX--.
- [Insulin resistance in the brain] impairs [insulin signaling] pathways critical for [synaptic plasticity[/entities/[long-term-potentiation[/entities/[long-term-potentiation[/entities/[long-term-potentiation--TEMP--/entities)--FIX-- and tau] phosphorylation.
- [GLP-1 receptor agonists[/treatments/[glp1-receptor-agonists[/treatments/[glp1-receptor-agonists[/treatments/[glp1-receptor-agonists--TEMP--/treatments)--FIX-- (e.g., semaglutide, liraglutide) are being investigated as neuroprotective agents, with promising epidemiological and early clinical trial data.
- Metformin use has been associated with reduced dementia risk in some observational studies.
Current smoking is associated with a 30–50% increased risk of dementia 1(](https://www.thelancet.com/commissions-do/dementia-prevention-intervention-and-care):
- Tobacco smoke promotes oxidative stress, vascular endothelial dysfunction, and neuroinflammation.
- Smoking cessation at any age reduces (but does not eliminate) excess dementia risk.
- Second-hand smoke exposure is also associated with cognitive decline.
Late-life depression is both a risk factor for and prodromal symptom of dementia 1(https://www.thelancet.com/commissions-do/dementia-prevention-intervention-and-care):
- Depression is associated with hippocampal atrophy, hypothalamic-pituitary-adrenal axis dysregulation, and elevated cortisol.
- Chronic depression promotes neuroinflammation via elevated pro-inflammatory cytokines and [microglial activation.
- Treatment of depression (pharmacotherapy, psychotherapy, physical activity may reduce dementia risk, though evidence from randomized trials is limited.
Social isolation and loneliness are increasingly recognized as major risk factors, with a population attributable fraction comparable to less education 1(](https://www.thelancet.com/commissions-do/dementia-prevention-intervention-and-care) 3(https://www.ucl.ac.uk/news/2024/jul/nearly-half-dementia-cases-could-be-prevented-or-delayed-tackling-14-risk-factors):
- Social engagement provides cognitive stimulation, emotional support, and motivation for health-promoting behaviors.
- Loneliness is associated with elevated cortisol, increased neuroinflammation, and accelerated cognitive decline.
- Social prescribing (community groups, volunteering, intergenerational programs) is emerging as a public health intervention.
Exposure to fine particulate matter (PM2.5) and nitrogen dioxide (NO₂) is associated with increased dementia incidence 1(https://www.thelancet.com/commissions-do/dementia-prevention-intervention-and-care):
- Ultrafine particles can cross the Blood-Brain Barrier and directly activate [microglial deposition and accelerated brain aging.
- Regulatory reduction of air pollution levels is a population-level prevention strategy.
Untreated vision loss in later life was added as a risk factor in the 2024 Lancet Commission update 1(](https://www.thelancet.com/commissions-do/dementia-prevention-intervention-and-care) 2(https://www.alzheimer-europe.org/news/2024-lancet-commission-underscores-potential-dementia-risk-reduction-identifying-14-modifiable?language_content_entity=en):
- Visual impairment reduces sensory input, social engagement, and physical activity—amplifying several other risk factors.
- Cataract surgery has been associated with a 29% reduction in dementia risk in observational studies.
- The mechanisms parallel those of hearing loss: sensory deprivation, increased cognitive load, and social withdrawal.
The Lancet Commission organizes prevention into a life-course model recognizing that risk factors operate at different ages 1(https://www.thelancet.com/commissions-do/dementia-prevention-intervention-and-care) 4(https://www.alzdiscovery.org/cognitive-vitality/blog/targeting-14-lifestyle-factors-may-prevent-up-to-45-of-dementia-cases):
| Life Phase |
Risk Factors |
Combined PAF |
| Early life (< 45 years) |
Less education |
5% |
| Midlife (45–65 years) |
Hearing loss, high LDL cholesterol, TBI, hypertension, excessive alcohol, obesity, physical inactivity |
23% |
| Later life (> 65 years) |
Smoking, depression, social isolation, air pollution, diabetes, vision loss |
18% |
| Total |
14 factors |
~45% |
Because risk factors cluster and interact (e.g., obesity promotes diabetes, which promotes hypertension), the actual preventable fraction is calculated using weighted models that account for comorbidity overlap and communality 1(https://www.thelancet.com/commissions-do/dementia-prevention-intervention-and-care) [5].
The 14 modifiable risk factors converge on several shared pathological mechanisms:
- Cerebrovascular damage: Hypertension, diabetes, obesity, smoking, and high LDL cholesterol promote [cerebral small vessel disease[/diseases/[cerebral-small-vessel-disease[/diseases/[cerebral-small-vessel-disease[/diseases/[cerebral-small-vessel-disease--TEMP--/diseases)--FIX--, white matter lesions, and Blood-Brain Barrier breakdown, reducing cerebral perfusion and waste clearance via the [glymphatic system[/entities/[glymphatic-system[/entities/[glymphatic-system[/entities/[glymphatic-system--TEMP--/entities)--FIX-- 5(https://pmc.ncbi.nlm.nih.gov/articles/PMC12509747/).
- neuroinflammation: Air pollution, obesity, depression, diabetes, and social isolation elevate systemic and central neuroinflammation, activating [microglia[/cell-types/[microglia[/cell-types/[microglia[/cell-types/[microglia--TEMP--/cell-types)--FIX--/entities/[microglia[/cell-types/[microglia[/cell-types/[microglia[/cell-types/[microglia--TEMP--/cell-types)--FIX-- and [astrocytes[/cell-types/[astrocytes[/cell-types/[astrocytes[/cell-types/[astrocytes--TEMP--/cell-types)--FIX-- to adopt pro-inflammatory phenotypes link.
- Reduced cognitive reserve: Less education, social isolation, physical inactivity, and sensory deprivation (hearing/vision loss) diminish [cognitive reserve[/mechanisms/[cognitive-reserve[/mechanisms/[cognitive-reserve[/mechanisms/[cognitive-reserve--TEMP--/mechanisms)--FIX--, lowering the threshold at which pathological brain changes produce clinical symptoms.
- Oxidative stress: Smoking, air pollution, diabetes, and excessive alcohol increase reactive oxygen species and oxidative stress, damaging [mitochondria[/entities/[mitochondrial-dynamics[/entities/[mitochondrial-dynamics[/entities/[mitochondrial-dynamics--TEMP--/entities)--FIX-- and promoting [protein aggregation[/mechanisms/[protein-aggregation[/mechanisms/[protein-aggregation[/mechanisms/[protein-aggregation--TEMP--/mechanisms)--FIX--.
- [Amyloid] and tau] acceleration: Several risk factors (high LDL cholesterol, diabetes, TBI, air pollution) directly promote [amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta--TEMP--/entities)--FIX-- deposition and tau] hyperphosphorylation], accelerating the core pathological cascades of AD.
¶ Multidomain Intervention Trials
Several randomized controlled trials have tested whether addressing multiple risk factors simultaneously can prevent cognitive decline:
- FINGER Trial (Finland): The landmark Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) demonstrated that a 2-year multidomain intervention (diet, exercise, cognitive training, vascular risk monitoring) improved cognitive performance by 25% relative to controls in at-risk older adults. The FINGER model has been replicated in over 40 countries worldwide 1(https://www.thelancet.com/commissions-do/dementia-prevention-intervention-and-care).
- [MAPT[/genes/[mapt[/genes/[mapt[/genes/[mapt--TEMP--/genes)--FIX-- (France) and PreDIVA (Netherlands): Showed more modest effects, possibly due to less intensive interventions or populations with lower baseline risk.
- World-Wide FINGERS Network: An international consortium of 46+ countries adapting the FINGER protocol to diverse populations and cultural contexts, generating the largest body of evidence on multidomain dementia prevention.
¶ Global and Equity Considerations
The burden of modifiable risk factors is not evenly distributed 5(https://pmc.ncbi.nlm.nih.gov/articles/PMC12509747/):
- Low- and middle-income countries (LMICs) bear 60% of the global dementia burden, with higher prevalence of risk factors (less education, air pollution, untreated hypertension and diabetes).
- The 2024 Lancet Commission emphasized that dementia prevention is inherently an issue of health equity—those with the least resources face the greatest risk.
- Sub-Saharan Africa has the highest proportion of potentially preventable dementia (over 50%) due to the high prevalence of untreated hypertension, diabetes, and limited educational access.
- Climate change and urbanization are projected to increase exposure to air pollution and heat stress, potentially amplifying dementia risk in vulnerable populations.
For clinicians and public health practitioners, the evidence supports several actionable strategies:
- Midlife cardiovascular risk management: Aggressive treatment of hypertension, diabetes, and high LDL cholesterol—ideally beginning in the 40s—has the greatest potential to reduce late-life dementia risk.
- Hearing and vision screening: Routine audiometry and vision assessment with provision of hearing aids, cataract surgery, and corrective lenses as needed.
- Physical activity promotion: Prescription of structured exercise programs, particularly for sedentary older adults.
- Social engagement: Screening for social isolation and referral to community-based social programs.
- Cognitive stimulation: Encouraging lifelong learning, occupational complexity, and cognitively stimulating leisure activities.
- Integrated care pathways: Combining cardiovascular risk reduction with cognitive screening in primary care settings [6].
- [GLP-1 Receptor[/entities/[glp1-receptor[/entities/[glp1-receptor[/entities/[glp1-receptor--TEMP--/entities)--FIX-- Agonists in Neurodegeneration/treatments/glp1-receptor-agonists)
The study of Modifiable Risk Factors For Dementia has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- [Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404(10452]:572-628. Lancet)
- [Alzheimer Europe. 2024 Lancet Commission underscores the potential for dementia risk reduction, identifying 14 modifiable risk factors across the life course. July 2024. Alzheimer Europe)
- [UCL News. Nearly half of dementia cases could be prevented or delayed by tackling 14 risk factors. July 2024. UCL)
- [Cognitive Vitality, Alzheimer's Drug Discovery Foundation. Targeting 14 lifestyle factors may prevent up to 45% of dementia cases. 2024. ADDF)
- [Suárez-Calvet M, Mukadam N, et al. Broadening dementia risk models: building on the 2024 Lancet Commission report for a more inclusive global framework. eClinicalMedicine. 2025. PMC)
- [Endalznow.org. Prevent or Delay Dementia by Addressing 14 Risk Factors. 2024. EndAlzNow)
- Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of [Alzheimer's disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX--: an analysis of population-based data. Lancet Neurol. 2014;13(8]:788-794.
- Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER]: a randomised controlled trial. Lancet. 2015;385(9984):2255-2263.
- World Health Organization. Risk reduction of cognitive decline and dementia: WHO guidelines. Geneva: WHO; 2019.
- Kivipelto M, Mangialasche F, Snyder HM, et al. World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia. Alzheimers Dement. 2020;16(7]:1078-1094.
🟡 Moderate Confidence
| Dimension |
Score |
| Supporting Studies |
10 references |
| Replication |
33% |
| Effect Sizes |
25% |
| Contradicting Evidence |
0% |
| Mechanistic Completeness |
75% |
Overall Confidence: 44%